303 related articles for article (PubMed ID: 12092667)
1. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
Pawlak D; Pawlak K; Malyszko J; Mysliwiec M; Buczko W
Int Urol Nephrol; 2001; 33(2):399-404. PubMed ID: 12092667
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.
Pawlak D; Tankiewicz A; Mysliwiec P; Buczko W
Nephron; 2002 Mar; 90(3):328-35. PubMed ID: 11867954
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine and its metabolites in the rat with experimental renal insufficiency.
Pawlak D; Tankiewicz A; Buczko W
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):755-66. PubMed ID: 11785771
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
Ryan KM; Allers KA; McLoughlin DM; Harkin A
Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
[TBL] [Abstract][Full Text] [Related]
5. Kynurenine metabolism in central nervous system in experimental chronic renal failure.
Topczewska-Bruns J; Pawlak D; Tankiewicz A; Chabielska E; Buczko W
Adv Exp Med Biol; 2003; 527():177-82. PubMed ID: 15206730
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of kynurenamines in the pathogenesis of cataract in diabetic patients.
Andrzejewska-Buczko J; Pawlak D; Tankiewicz A; Matys T; Buczko W
Med Sci Monit; 2001; 7(4):742-5. PubMed ID: 11433204
[TBL] [Abstract][Full Text] [Related]
7. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
Badawy AA
Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
[TBL] [Abstract][Full Text] [Related]
8. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
[TBL] [Abstract][Full Text] [Related]
9. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
10. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
11. Formation of kynurenic and xanthurenic acids from kynurenine and 3-hydroxykynurenine in the dinoflagellate Lingulodinium polyedrum: role of a novel, oxidative pathway.
Zsizsik BK; Hardeland R
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Nov; 133(3):383-92. PubMed ID: 12379423
[TBL] [Abstract][Full Text] [Related]
12. Computer simulation and analysis of tryptophan metabolism via kynurenine pathway in liver.
Heinmets F
Comput Biol Med; 1974 Sep; 1(4):323-36. PubMed ID: 4600391
[No Abstract] [Full Text] [Related]
13. Kynurenine metabolism and xanthurenic acid formation in vitamin B6-deficient rat after tryptophan injection.
Takeuchi F; Tsubouchi R; Izuta S; Shibata Y
J Nutr Sci Vitaminol (Tokyo); 1989 Apr; 35(2):111-22. PubMed ID: 2732805
[TBL] [Abstract][Full Text] [Related]
14. New insights into tryptophan and its metabolites in the regulation of bone metabolism.
Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D
J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay.
Nayak BN; Buttar HS
J Complement Integr Med; 2016 Jun; 13(2):129-36. PubMed ID: 26641976
[TBL] [Abstract][Full Text] [Related]
16. [Kynurenines in pathogenesis of endogenous psychiatric disorders].
Shilov IuE; Bezrukov MV
Vestn Ross Akad Med Nauk; 2013; (1):35-41. PubMed ID: 23805637
[TBL] [Abstract][Full Text] [Related]
17. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK
Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952
[TBL] [Abstract][Full Text] [Related]
18. Relationship between tryptophan intake and urinary excretion of 3-hydroxy-kynurenine, 3-hydroxyanthranilic acid, xanthurenic acid and kynurenic acid.
Watanabe M; Takahashi T; Yoshida M; Suzuki M; Muramatsu S
J Nutr Sci Vitaminol (Tokyo); 1979; 25(2):115-22. PubMed ID: 479960
[No Abstract] [Full Text] [Related]
19. Central kynurenine pathway shift with age in women.
de Bie J; Guest J; Guillemin GJ; Grant R
J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
[TBL] [Abstract][Full Text] [Related]
20. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17():47. PubMed ID: 27130315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
